Notice is hereby given that the following changes have been made to the proposed rule in accordance with subparagraph 120.54(3)(d)1., F.S., published in Vol. 36 No. 2, January 15, 2010 issue of the Florida Administrative Weekly.

Subsection (5)(k) shall now read as follows:

(k) Ketorolac tromethamine – 0.4%, 0.5%;

Subsection (6)(h) is being added and shall now read as follows:

(h) Bepotastine besilate – 1.5%

Subsection (7) shall now read as follows:

(7) ANTIVIRAL AGENTS

(a) Trifluridine – 1.0%.

(b) Ganciclovir – 0.15%.

NAME OF PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Joe Baker, Jr., Executive Director, Board of Optometry/MQA, 4052 Bald Cypress Way, Bin #C07, Tallahassee, FL 32399